Former Pfizer chief claims Covid-19 pandemic effectively over, no need for any vaccine
Says vaccination is unnecessary on healthy people who arent at risk from the disease28-11-2020
Former Pfizer chief claims Covid-19 pandemic effectively over, no need for any vaccine
Says vaccination is unnecessary on healthy people who arent at risk from the diseasePfizer vs Moderna vs AstraZeneca! Whose efficacy to trust?
New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy bandPFIZER LTD. - 500680 - Disclosure Under Regulation 23(9) Of The SEBI (LODR) 2015
Pursuant to Regulation 23(9) of the SEBI (LODR) 2015, please find enclosed, disclosure of related party transactions for the half year ended September 30, 2020. The said disclosure is also available on the website of the Company i.e., www.pfizerindia.com. Please take the same on record.Pfizer distances itself from Covid-19-linked vaccine tourism advertisement
The social media message from a tour operator claimed that it could help travellers be the first to get a Corona vaccine.Coronavirus Vaccine | From cost, efficacy, availability to storage, here's everything you need to know about frontrunners
Pfizer-BioNTech's vaccine has shown 95 percent efficacy while Moderna's is 94.5 percent effective but they need some of the coldest temperatures for storage. Oxford-AstraZeneca's vaccine is 70 percent effective and can be handled at normal refrigerated conditions, hence best suited for India.COVID-19 vaccine update: Pfizer files for emergency use; Covaxin trials to start in metro cities
Bharat Biotech, the developer of India's indigenous vaccine Covaxin, has said that it is planning to enrol about 2,000 participants each in metros for Phase-3 trials of its COVID-19 vaccine that began earlier this weekPfizer approaches USFDA to secure emergency use authorisation for COVID vaccine
Pfizer that its EUA submission is supported by solicited safety data from a randomised subset of approximately 8,000 participants aged 18 years or above and unsolicited safety data from approximately 38,000 trial participantsItaly to start COVID-19 vaccinations in January 2021
Italy is set to receive 3.4 million doses of Pfizer's COVID-19 vaccine in January, enough to provide the requisite two doses to 1.6 million of the country's 60 million people, according to Special Commissioner Domenico Arcuri.Record Covid-19 deaths in Delhi, Pfizer's '95% effective' vaccine, and more
With medical facilities under strain, as many as 45 doctors and 160 paramedics of the paramilitary forces have also arrived in the capital to serve the peoplePfizer, Moderna Covid-19 vaccines may be authorised for use within weeks
States and territories are prepared to begin distributing the vaccines within 24 hours of receiving regulatory authorization